Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Cited In for PubMed (Select 20346098)

1.

Special suppressive role of miR-29b in HER2-positive breast cancer cells by targeting Stat3.

Qin L, Li R, Zhang J, Li A, Luo R.

Am J Transl Res. 2015 May 15;7(5):878-90. eCollection 2015.

2.

Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma.

Severino P, Oliveira LS, Andreghetto FM, Torres N, Curioni O, Cury PM, Toporcov TN, Paschoal AR, Durham AM.

BMC Med Genomics. 2015 Jun 24;8:31. doi: 10.1186/s12920-015-0102-4.

3.

microRNA therapies in cancer.

Rothschild SI.

Mol Cell Ther. 2014 Mar 4;2:7. doi: 10.1186/2052-8426-2-7. eCollection 2014. Review.

4.

Differentially expressed microRNAs in postpartum breast cancer in Hispanic women.

Muñoz-Rodríguez JL, Vrba L, Futscher BW, Hu C, Komenaka IK, Meza-Montenegro MM, Gutierrez-Millan LE, Daneri-Navarro A, Thompson PA, Martinez ME.

PLoS One. 2015 Apr 13;10(4):e0124340. doi: 10.1371/journal.pone.0124340. eCollection 2015.

5.

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA.

Hayes EL, Lewis-Wambi JS.

Breast Cancer Res. 2015 Mar 17;17:40. doi: 10.1186/s13058-015-0542-y.

6.

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.

van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2015 Feb 18;17:21. doi: 10.1186/s13058-015-0526-y.

7.

A let-7b binding site SNP in the 3'-UTR of the Bcl-xL gene enhances resistance to 5-fluorouracil and doxorubicin in breast cancer cells.

Wang T, Huang B, Guo R, Ma J, Peng C, Zu X, Tang H, Lei X.

Oncol Lett. 2015 Apr;9(4):1907-1911. Epub 2015 Feb 6.

8.

MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.

Cho JH, Dimri M, Dimri GP.

J Biol Chem. 2015 Apr 17;290(16):10555-67. doi: 10.1074/jbc.M114.624361. Epub 2015 Mar 3.

PMID:
25737447
9.

Analysis of miRNA expression profiles in breast cancer using biclustering.

Fiannaca A, La Rosa M, La Paglia L, Rizzo R, Urso A.

BMC Bioinformatics. 2015;16 Suppl 4:S7. doi: 10.1186/1471-2105-16-S4-S7. Epub 2015 Feb 23.

10.

MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.

Sun Q, Liu T, Zhang T, Du S, Xie GX, Lin X, Chen L, Yuan Y.

Mol Med Rep. 2015 May;11(5):3330-6. doi: 10.3892/mmr.2015.3221. Epub 2015 Jan 19.

11.

From microRNA target validation to therapy: lessons learned from studies on BDNF.

Varendi K, Mätlik K, Andressoo JO.

Cell Mol Life Sci. 2015 May;72(9):1779-94. doi: 10.1007/s00018-015-1836-z. Epub 2015 Jan 20. Review.

12.

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.

Sidiropoulos KG, White NM, Bui A, Ding Q, Boulos P, Pampalakis G, Khella H, Samuel JN, Sotiropoulou G, Yousef GM.

Oncoscience. 2014 Oct 24;1(11):709-24. eCollection 2014.

13.

MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1.

Yin F, Zhang JN, Wang SW, Zhou CH, Zhao MM, Fan WH, Fan M, Liu S.

PLoS One. 2015 Jan 5;10(1):e0116759. doi: 10.1371/journal.pone.0116759. eCollection 2015.

14.

Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.

Li D, Jian W, Wei C, Song H, Gu Y, Luo Y, Fang L.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7672-80. eCollection 2014.

15.

Integration of genomic data enables selective discovery of breast cancer drivers.

Sanchez-Garcia F, Villagrasa P, Matsui J, Kotliar D, Castro V, Akavia UD, Chen BJ, Saucedo-Cuevas L, Rodriguez Barrueco R, Llobet-Navas D, Silva JM, Pe'er D.

Cell. 2014 Dec 4;159(6):1461-75. doi: 10.1016/j.cell.2014.10.048. Epub 2014 Nov 26.

PMID:
25433701
16.

MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis.

Filios SR, Xu G, Chen J, Hong K, Jing G, Shalev A.

J Biol Chem. 2014 Dec 26;289(52):36275-83. doi: 10.1074/jbc.M114.592360. Epub 2014 Nov 12.

PMID:
25391656
17.

Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.

Bailey ST, Westerling T, Brown M.

Cancer Res. 2015 Jan 15;75(2):436-45. doi: 10.1158/0008-5472.CAN-14-1041. Epub 2014 Nov 11.

PMID:
25388283
18.

hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.

Dobson JR, Taipaleenmäki H, Hu YJ, Hong D, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Pratap J.

Cancer Cell Int. 2014 Aug 2;14:73. doi: 10.1186/s12935-014-0073-0. eCollection 2014.

19.
20.

Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery.

Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, Xiao ZD.

J Biol Chem. 2014 Aug 8;289(32):22258-67. doi: 10.1074/jbc.M114.588046. Epub 2014 Jun 20.

PMID:
24951588
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk